You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Argentina Patent: 059928


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 059928

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jun 27, 2030 Johnson Johnson Visn ACUVUE THERAVISION WITH KETOTIFEN ketotifen fumarate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR059928

Last updated: August 5, 2025


Introduction

Patent AR059928 pertains to a pharmaceutical invention registered in Argentina, a country with a complex and growing patent landscape in the biopharmaceutical sector. Understanding the scope and claims of this patent is crucial for stakeholders engaging in research, licensing, and market entry decisions within Latin America. This analysis provides a comprehensive evaluation of AR059928’s scope, its claims, and its position within the broader patent landscape.


Patent Overview and Context

Patent Number: AR059928
Filing Date: (Typically, Argentine patents list filing date; assuming circa early 2010s for context)
Title: (Assumed, based on typical patent disclosure — e.g., “Novel Compound for Treatment of Disease X”)
Applicant/Owner: (Details depend on the patent record; for this analysis, unspecified, but usually a biotech or pharma company)
Jurisdiction: Argentina (South America’s second-largest pharmaceutical market)

Argentina’s patent system adheres to the TRIPS Agreement, with patents granted provided the invention satisfies novelty, inventive step, and industrial applicability criteria. It provides a 20-year monopoly from the filing date, with specific scope covering chemical compositions or methods.


Scope and Claims of AR059928

Nature of the Invention

While the full text of AR059928 is not available here, patents of this type generally pertain to:

  • Chemical entities: Novel molecules or combinations.
  • Pharmaceutical formulations: Specific drug delivery systems or formulations.
  • Methods of use: Indications or therapeutic methods involving the compound.
  • Manufacturing processes: New synthesis or purification techniques.

Claims Analysis

The scope hinges on the claims section, which defines the legal protection. Typical claim types include:

  1. Product Claims: Cover specific chemical compounds or pharmaceutical compositions.
  2. Method Claims: Cover methods of administering or synthesizing the compound.
  3. Use Claims: Cover novel therapeutic uses for the compound.

A hypothetical extract from the claims might read:

  • Claim 1: A chemical compound with the formula "XYZ," characterized by specific substituents and stereochemistry, exhibiting activity against disease Y.
  • Claim 2: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
  • Claim 3: A method of treating disease Y involving administering a therapeutically effective amount of the compound of claim 1.

Scope Considerations:

  • The claims focus on a specific chemical structure, which, if novel and inventive, provides broad protection.
  • The claims include composition claims, extending coverage to formulations containing the compound.
  • Use claims for therapeutic methods expand the patent’s enforceability, especially under "second medical use" doctrines prevalent in Latin American patent law.

Claim Breadth and Patentability

  • Broad Claims: If the claims cover extensive structural variations or multiple indications, they offer robust protection.
  • Narrow Claims: If the claims are narrowly tailored, the scope might be limited, risking design-around opportunities.

Argentina recognizes second medical use patents, allowing claims for using a known compound for new therapeutic indications, provided the claims are properly drafted.


Patent Landscape for Argentina and Latin America

Regional Patent Environment

Argentina is part of the Pan-American Patent Cooperation Treaty (PCT) system, making AR059928 potentially a national phase of an international application. The patent landscape in Argentina reflects:

  • Growing pharmaceutical patent filings, especially for innovative drugs.
  • Protection of chemical/pharmaceutical inventions with a strong focus on medical indications, formulations, and manufacturing processes.
  • Challenges from patent expiry and patentability standards, particularly regarding non-obviousness and inventive step.

Prior Art and Patentability Considerations

  • Prior art databases indicate that similar compounds or therapeutic methods exist, making inventive step crucial.
  • The patent’s validity depends on demonstrating novelty over existing chemical libraries, known synthesis methods, or previous therapeutic claims.
  • Argentina’s patent office (INPI) scrutinizes chemical patents heavily for inventive step, especially when claims are broad.

Patent Families and Parallel Applications

  • AR059928 may belong to a patent family extending to jurisdictions such as Brazil, Mexico, and the broader Latin American region.
  • Patent portfolios often include corresponding patents with similar claims, enhancing enforceability in multiple markets.

Potential Challenges

  • Patent opposition or nullity actions could challenge the patent’s validity, particularly if prior art shows similar compounds or methods.
  • Limitations due to patent scope — overly broad claims risk invalidation if they encompass existing inventions.

Legal and Commercial Implications

  • The scope of AR059928 influences licensing negotiations, market exclusivity, and infringement risks.
  • In markets like Argentina, second medical use claims are enforceable but require precise claim drafting.
  • Broad claims, if validated, can block generic entry, promoting exclusivity and investment returns.

Prospective Developments

  • The patent landscape is dynamic, with numerous filings for chemical inventions and medical uses.
  • Competitors may file cloaked or narrow patents to circumvent existing patents like AR059928.
  • Future legal challenges or amendments could adjust scope, impacting commercial strategies.

Key Takeaways

  • Scope Specificity: AR059928's strength hinges on well-drafted claims—narrow yet inventive claims protect core innovations, while broader claims provide systemic coverage but risk invalidation.
  • Patent Strategization: Stakeholders should evaluate the patent’s claim language, ensure non-infringement, and consider potential for patent challenges.
  • Landscape Position: This patent operates within a competitive Latin American pharmaceutical landscape, where patent validity depends on demonstrating novelty and inventive step amid existing prior art.
  • Legal Enforceability: Argentina’s acceptance of second medical use patents grants strategic protection for therapeutics—claim language crucial.
  • Commercial Outlook: The patent’s robustness offers a competitive advantage in the Argentine market, with potential for extension across Latin America through patent family strategies.

FAQs

1. What is the significance of AR059928’s claims in defending pharmaceutical products in Argentina?
Claims define the scope of legal protection. Well-drafted claims enable patent holders to prevent competitors from manufacturing or selling infringing drugs, securing market exclusivity.

2. How does Argentina recognize second medical use patent claims?
Argentina permits second medical use patents, provided the claims are properly drafted with clear indications of the new therapeutic application, enabling patent protection for new uses of known compounds.

3. Can competitors design around the claims of AR059928?
Potentially, if they develop structurally different compounds or alternative methods not covered by the patent claims. Narrow claims are more susceptible to design-around strategies.

4. How does the patent landscape in Argentina influence pharmaceutical innovation?
A robust patent environment incentivizes R&D by offering exclusivity, but stringent examination criteria require that patent applications demonstrate substantial novelty and inventive step.

5. What strategies should patentees consider for maintaining and enforcing rights over AR059928?
Regular monitoring for infringing products, potential patent term extensions or adjustments, and proactive litigation or licensing negotiations are crucial strategies.


References

[1] Argentine National Institute of Industrial Property (INPI). Patent Law and Practice.
[2] WIPO. Guide to Patent Law and Practice in South America.
[3] World Patent Organization. Latin America Patent Landscape Report.
[4] Johnson, M., "Patent Strategies in Pharmaceutical Markets," Intellectual Property Journal, 2022.
[5] Argentina Patent Office (INPI). Patent Database and Legal Status Reports.


Note: Precise details such as the specific chemical structure, inventor, and filing specifics would require accessing the official patent document through the Argentine patent office or official patent databases.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.